Globe Life Inc. Announces Fourth Quarter 2019 Earnings Release And Conference Call
MCKINNEY, Texas, Jan. 20, 2020 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will release Fourth Quarter 2019 earnings after the market closes on Tuesday, Feb. 4, 2020. At that time a copy of the Company's Q4 - 2019 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at https://investors.globelifeinsurance.com/ under Calls and Meetings. In conjunction with the Fourth Quarter 2019 Earnings Release of Globe Life Inc. you are invited to listen to a conference call that will be broadcast live over the Internet on Wednesday, Feb 5, 2020 at 12:00 pm Eastern (11:00 am Central).
Globe Life Inc. is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies.
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.
Alicia brings over 25 years of investing experience with deep relationships and...
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...
